Aeglea BioTherapeutics CEO Anthony Quinn's 2019 pay falls 35% to $2.5M
Aeglea BioTherapeutics reports 2019 executive compensation
By ExecPay News
Published: April 23, 2020
Aeglea BioTherapeutics reported fiscal year 2019 executive compensation information on April 23, 2020.
In 2019, three executives at Aeglea BioTherapeutics received on average a compensation package of $1.6M, a 15% decrease compared to previous year.
Average pay of disclosed executives at Aeglea BioTherapeutics
Anthony G. Quinn, Chief Executive Officer, received $2.5M in total, which decreased by 35% compared to 2018. 67% of Quinn's compensation, or $1.7M, was in stock awards. Quinn also received $247K in non-equity incentive plan, $518K in salary, as well as $54K in other compensation.
Leslie Sloan, Chief Operating Officer, received a compensation package of $1.1M. 55% of the compensation package, or $632K, was in stock awards.
Charles N. York II, Chief Financial Officer, earned $1.1M in 2019, a 13% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 23, 2020.